Kiora Pharmaceuticals, Inc. (KPRX) Stock

Healthcare · Biotechnology · Member of Other US Stocks

Kiora Pharmaceuticals, Inc. (KPRX) closed at USD 2.47 on 2026-10-14, a change of +0.6 % over the past year, with a market capitalization of USD 10.66M.

Kiora Pharmaceuticals, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Kiora Pharmaceuticals, Inc. key figures

Previous close

USD 2.47 (2026-10-14)

1-year change

+0.6 %

Market cap

USD 10.66M

Enterprise value

USD -1.17M

P/E ratio (trailing)

-1.01

P/E ratio (forward)

-1.08

EPS (trailing)

-2.38

EPS (forward)

-2.23

PEG ratio

n/a

Price to book

0.91

Revenue growth

n/a

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

0.25

Employees

13

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Kiora Pharmaceuticals, Inc.

Kiora Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, engages in the development and commercialization of therapies for the treatment of ophthalmic diseases. Its lead product is KIO-301, a potential vision-restoring small molecule, which is in Phase 2 clinical trials for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease. The company is also developing KIO-104, a non-steroidal, immuno-modulatory, small-molecule inhibitor of dihydroorotate dehydrogenase, which is in phase 1b/2a study for the treatment of posterior non-infectious uveitis, as well as under pre-clinical development for the treatment of proliferative vitreoretinopathy; and KIO-101, an eye drop formulation for the treatment of ocular presentation of rheumatoid arthritis. It has a strategic development and commercialization agreement with Théa Open Innovation for the development of KIO-301. The company operates in the United States, Austria, and Australia. The company was formerly known as Eyegate Pharmaceuticals, Inc. and changed its name to Kiora Pharmaceuticals, Inc. in November 2021. Kiora Pharmaceuticals, Inc. was incorporated in 1998 and is headquartered in Encinitas, California.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Kiora Pharmaceuticals, Inc. and compare it with other stocks.